ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 96 filers reported holding ENZO BIOCHEM INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $741,000 | +25.6% | 215,319 | -8.1% | 0.00% | – |
Q4 2020 | $590,000 | +16.8% | 234,229 | -2.1% | 0.00% | – |
Q3 2020 | $505,000 | -21.6% | 239,354 | -16.8% | 0.00% | – |
Q2 2020 | $644,000 | +51.2% | 287,582 | +70.7% | 0.00% | – |
Q1 2020 | $426,000 | -25.8% | 168,487 | -22.9% | 0.00% | – |
Q4 2019 | $574,000 | -55.8% | 218,409 | -39.5% | 0.00% | -100.0% |
Q3 2019 | $1,300,000 | +77.4% | 361,219 | +66.0% | 0.00% | – |
Q2 2019 | $733,000 | – | 217,666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 1,047,732 | $5,333,000 | 2.30% |
KOPP INVESTMENT ADVISORS LLC | 232,099 | $1,181,000 | 1.17% |
GLOBEFLEX CAPITAL L P | 225,834 | $1,149,000 | 0.29% |
KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $356,000 | 0.24% |
Breithorn Capital Management | 63,324 | $322,000 | 0.24% |
Acrospire Investment Management LLC | 55,444 | $282,000 | 0.19% |
EAM Investors, LLC | 267,368 | $1,361,000 | 0.18% |
Granahan Investment Management | 875,002 | $4,454,000 | 0.15% |
Geduld E E | 15,000 | $76,000 | 0.08% |
GILDER GAGNON HOWE & CO LLC | 872,009 | $4,439,000 | 0.08% |